Argos Wealth Advisors LLC Buys New Position in Proto Labs, Inc. $PRLB

Argos Wealth Advisors LLC bought a new stake in shares of Proto Labs, Inc. (NYSE:PRLB) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 8,173 shares of the industrial products company’s stock, valued at approximately $413,000.

Other hedge funds also recently added to or reduced their stakes in the company. NewEdge Advisors LLC increased its position in Proto Labs by 7,380.0% during the 1st quarter. NewEdge Advisors LLC now owns 748 shares of the industrial products company’s stock valued at $26,000 after buying an additional 738 shares in the last quarter. NBC Securities Inc. purchased a new stake in shares of Proto Labs in the fourth quarter worth about $46,000. Aquatic Capital Management LLC purchased a new stake in shares of Proto Labs in the third quarter worth about $64,000. CWM LLC boosted its stake in shares of Proto Labs by 80.8% in the third quarter. CWM LLC now owns 2,589 shares of the industrial products company’s stock worth $130,000 after buying an additional 1,157 shares during the last quarter. Finally, Tower Research Capital LLC TRC boosted its stake in shares of Proto Labs by 363.0% in the second quarter. Tower Research Capital LLC TRC now owns 2,806 shares of the industrial products company’s stock worth $112,000 after buying an additional 2,200 shares during the last quarter. 84.54% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on PRLB. Weiss Ratings upgraded Proto Labs from a “hold (c)” rating to a “hold (c+)” rating in a research note on Wednesday, May 6th. Zacks Research downgraded Proto Labs from a “strong-buy” rating to a “hold” rating in a research note on Friday, April 10th. Three analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $53.33.

Proto Labs Price Performance

NYSE PRLB opened at $70.98 on Wednesday. The company has a market cap of $1.69 billion, a PE ratio of 66.96 and a beta of 1.36. The stock’s 50 day simple moving average is $61.02 and its 200-day simple moving average is $56.63. Proto Labs, Inc. has a 1-year low of $36.15 and a 1-year high of $71.55.

Proto Labs (NYSE:PRLB) last released its earnings results on Friday, May 1st. The industrial products company reported $0.54 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.14. Proto Labs had a return on equity of 4.15% and a net margin of 4.71%.The business had revenue of $139.34 million for the quarter, compared to the consensus estimate of $135.31 million. During the same quarter last year, the business posted $0.33 earnings per share. The business’s quarterly revenue was up 10.4% compared to the same quarter last year. Proto Labs has set its Q2 2026 guidance at 0.500-0.580 EPS. On average, equities research analysts anticipate that Proto Labs, Inc. will post 1.37 EPS for the current fiscal year.

Proto Labs Company Profile

Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.

Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.